These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Nicotinic acid and fibrinolysis in humans. II. Tachyphylaxis and dynamic fibrinolytic reactivation (general and regional), caused by "venous" and "arterial" administration of nicotinic acid]. Tesi M, Brunetti S, Caramelli L. Riv Crit Clin Med; 1967 Dec; 67(6):484-507. PubMed ID: 5603692 [No Abstract] [Full Text] [Related]
4. A study of the mechanism of fibrinolytic system activation by nicotinate in patients with liver cirrhosis. Prokopowicz J, Gabryelewicz S, Wolosowicz N, Szalaj W, Merkiel K, Mielech H, Langiewicz J. Mater Med Pol; 1976 Dec; 8(1):43-7. PubMed ID: 1263583 [No Abstract] [Full Text] [Related]
5. [Effect of plasminogen activator present in the endothelium of venous vessels on the development of thrombotic diseases]. Czestochowska E. Pol Tyg Lek; 1974 Apr 08; 29(14):587-9. PubMed ID: 4828036 [No Abstract] [Full Text] [Related]
7. [Nicotinic acid and fibrinolysis in humans. I. Regional fibrinolysis (cerebral, of the upper extremity and of the lower extremity) caused by "arterial" administration of nicotinic acid]. Tesi M. Riv Crit Clin Med; 1967 Dec 08; 67(6):465-83. PubMed ID: 5603691 [No Abstract] [Full Text] [Related]
8. Effects on the human fibrinolytic system of prolonged intravenous infusion of high doses of Complamin (xantinol nicotinate). Bouvier CA, Berthoud S. Helv Med Acta; 1968 Mar 08; 34(2):170-86. PubMed ID: 4232105 [No Abstract] [Full Text] [Related]
10. [Clinical and experimental research on prolonged fibrinolytic treatment. 2. Activation of fibrinolysis by prolonged administration of nicotinic acid derivatives]. De Nicola P, Gibelli A, Frandoli G, Turazza G. Hemostase; 1965 Dec 08; 5(4):343-51. PubMed ID: 5880346 [No Abstract] [Full Text] [Related]
11. Some investigations into the reserve fibrinolytic activity in patients with febrile and thrombo-embolic diseases. van Walree RN, den Ottolander GJ. Hemostase; 1966 Oct 08; 6(4):233-40. PubMed ID: 5986047 [No Abstract] [Full Text] [Related]
12. The effect of tranexamic acid on the fibrinolytic activity of vein walls. Astedt B, Liedholm P, Wingerup L. Ann Chir Gynaecol; 1978 Oct 08; 67(6):203-5. PubMed ID: 742821 [Abstract] [Full Text] [Related]
13. [Variations in fibrinolytic activity and fibrinogen caused by xanthinol nicotinate in cases of diabetes mellitus with peripheral vascular lesions]. Ipbüker A, Bayer H. Turk Tip Cemiy Mecm; 1969 Apr 08; 35(4):236-46. PubMed ID: 5810400 [No Abstract] [Full Text] [Related]
17. [Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries]. Kiersnowska B, Bielawiec M, Lukjan H, Korfel B, Rogowski F, Dowzyk W. Pol Tyg Lek; 1973 Mar 12; 28(11):400-3. PubMed ID: 4694796 [No Abstract] [Full Text] [Related]